REQUEST A DEMO
Total
USD $0.00
Search more companies

Yung Shin Pharm. Ind. Co., Ltd. (永信药品工业股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Yung Shin Pharm. Ind. Co., Ltd. Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Yung Shin Pharm. Ind. Co., Ltd. (永信药品工业股份有限公司) is a company based in Taiwan, China, with its head office in Taichung City. The enterprise operates in the Pharmaceutical and Medicine Manufacturing industry. It was incorporated on August 26, 1965. 1,267 (2023) employees currently work for Yung Shin Pharm. Ind. Co., Ltd. (永信药品工业股份有限公司). The company’s latest financial report indicates a net sales revenue increase of 13.58% in Q2C2025. Its’ total assets recorded a growth of 5.93%. The net profit margin of Yung Shin Pharm. Ind. Co., Ltd. (永信药品工业股份有限公司) increased by 2.9% in 2025.

Headquarters
No.1191,Section 1, Chung Shan Road, Tachia
Taichung City; Taichung City;

Contact Details: Purchase the Yung Shin Pharm. Ind. Co., Ltd. (永信药品工业股份有限公司) report to view the information.

Website: http://www.ysp.com.tw

Basic Information
Total Employees:
Purchase the Yung Shin Pharm. Ind. Co., Ltd. (永信药品工业股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Yung Shin Pharm. Ind. Co., Ltd. (永信药品工业股份有限公司) report to view the information.
Financial Auditors:
Purchase the Yung Shin Pharm. Ind. Co., Ltd. (永信药品工业股份有限公司) report to view the information.
Incorporation Date:
August 26, 1965
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
General Manager
Subsidiaries
永甲興業股份有限公司
73.5%
Company Performance
Financial values in the chart are available after Yung Shin Pharm. Ind. Co., Ltd. (永信药品工业股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
13.58%
Total Operating Revenue
13.65%
Operating Profit
39.83%
EBITDA
33.46%
Net Profit/Loss for the Period
37.86%
Total Assets
5.93%
Total Equity
7.58%
Operating Profit Margin
3.9%
Net Profit Margin
2.9%
Return on Equity (ROE)
2.44%
Debt / Equity
3759%
Quick Ratio
349.86%
Cash Ratio
0.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?